AMG National Trust Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

AMG National Trust Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Sell	1,956 -3,422	-64%	-$2.33M	0.03%	249
2026 Q1	$4.16M	Sell	5,378 -161	-3%	-$123K	0.09%	141
2025 Q4	$4.28M	Sell	5,539 -249	-4%	-$169K	0.1%	120
2025 Q3	$3.25M	Sell	5,788 -181	-3%	-$102K	0.08%	147
2025 Q2	$3.13M	Buy	+5,969	New	+$3.33M	0.08%	141
2024 Q4	–	Sell	-220	Closed	-$231K	–	462
2024 Q3	$231K	Buy	220 +28	+15%	+$31.2K	0.01%	412
2024 Q2	$202K	Buy	+192	New	+$186K	0.01%	434

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AMG National Trust Bank's REGN Position: Q2 2026 in Review

AMG National Trust Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 64% in Q2 2026, selling an estimated $2.33M and leaving 1,956 shares worth $1.22M. The position accounts for 0.03% of the portfolio, ranked #249.

AMG National Trust Bank first reported a position in REGN in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.28M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

AMG National Trust Bank held 1,956 shares of Regeneron Pharmaceuticals worth $1.22M as of Q2 2026.
AMG National Trust Bank sold 3,422 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.33M.
Regeneron Pharmaceuticals made up 0.03% of AMG National Trust Bank's portfolio in Q2 2026, its #249 holding.
AMG National Trust Bank first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
AMG National Trust Bank's Regeneron Pharmaceuticals position peaked at $4.28M in Q4 2025.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.